Amitriptyline supersensitizes a central cholinergic mechanism
dc.contributor.author | Dilsaver, Steven C. | en_US |
dc.contributor.author | Snider, R. Michael | en_US |
dc.contributor.author | Alessi, Norman E. | en_US |
dc.date.accessioned | 2006-04-07T19:55:20Z | |
dc.date.available | 2006-04-07T19:55:20Z | |
dc.date.issued | 1987-04 | en_US |
dc.identifier.citation | Dilsaver, Steven C., Snider, R. Michael, Alessi, Norman E. (1987/04)."Amitriptyline supersensitizes a central cholinergic mechanism." Biological Psychiatry 22(4): 495-507. <http://hdl.handle.net/2027.42/26759> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T4S-482R96P-2P/2/ef22b8b9e0b4352d6e751cd6bdf64315 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26759 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3567263&dopt=citation | en_US |
dc.description.abstract | The withdrawal of tricyclic antidepressants produces symptoms characteristic of cholinergic overdrive states. The authors previously proposed that these states are the consequence of the pharmacological induction of cholinergic system supersensitivity by chronic treatment with antidepressants, combined with a reduction in the plasma level of a competitive muscarinic receptor antagonist when the dose of a tricyclic is decreased. This is consistent with the facts that all tricyclic antidepressants are antimuscarinic agents and that classical antimuscarinic compounds, such as scopolamine, up-regulate and supersensitize muscarinic cholinergic systems. The authors present evidence that chronic treatment with amitriptyline supersensitizes a central cholinergic mechanism. Core body temperature is subject to influence by a central (hypothalamic) muscarinic mechanism, which is rendered supersensitive to cholinomimetic challenge by treatment with scopolamine. The authors telemetrically measured the hypothermic responses of adult male rats to various doses of the muscarinic agonist oxotremorine before and in the course of chronic treatment with amitriptyline. Treatment with amitriptyline resulted in marked enhancement of the cholinomimetic-induced hypothermia. Methylscopolamine nitrate, a peripherally active antimuscarinic agent, did not block the hypothermic response to oxotremorine, whereas scopolamine, a centrally active antimuscarinic compound, did. This study indicates that the chronic administration of amitriptyline can produce supersensitivity of a central muscarinic cholinergic mechanism. Clinical and theoretical implications of this finding are discussed. | en_US |
dc.format.extent | 873532 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Amitriptyline supersensitizes a central cholinergic mechanism | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Neuroscience Laboratory, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Mental Health Research Institute, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Mental Health Research Institute, USA | en_US |
dc.identifier.pmid | 3567263 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26759/1/0000311.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0006-3223(87)90171-5 | en_US |
dc.identifier.source | Biological Psychiatry | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.